Considering a cellular clinical viewpoint, Relafen 750 (Naproxen) exhibits unique properties . It functions primarily as a cyclooxygenase medication , preferentially inhibiting cyclooxygenase-2 (COX-2), an protein participating in prostaglandin formation. This specific inhibition generates reduced inflammation and discomfort , delivering potential